Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Other stimulant use, unspecified with stimulant-induced psychotic disorder with delusions (ICD-10 Code: F15.950)
Summary
This code applies to cases of stimulant use where a stimulant-induced psychotic disorder with delusions is present, but the clinical documentation does not specify additional details about the pattern or severity of use. It is used when the focus is on the psychotic symptoms (specifically delusions) resulting from stimulant use without further classification of dependence, abuse, or other complications. Stimulants include substances like amphetamines, methamphetamine, or prescription medications that increase central nervous system activity.
Causes
Stimulant-induced psychotic disorder with delusions may result from recreational or therapeutic use of these substances. The unspecified nature of this code suggests insufficient documentation to determine the exact pattern of use, such as whether it involves dependence or abuse, beyond the psychotic symptoms with delusions.
Risk Factors
- History of substance use or addiction.
- Access to stimulant medications or illicit drugs.
- High-stress environments or peer pressure.
- Pre-existing mental health conditions (e.g., anxiety, depression).
- Genetic or familial predisposition to substance-related issues.
Symptoms
Symptoms depend on the type and amount of stimulant used but may include persistent delusions (fixed false beliefs), hallucinations, or disorganized thinking. Physiological effects like elevated heart rate or blood pressure may also occur, alongside psychological effects such as agitation or paranoia.
Diagnosis
Diagnosis requires clinical evaluation to confirm stimulant use and the presence of psychotic symptoms with delusions. Documentation should support the temporal relationship between stimulant use and symptom onset. Laboratory tests or imaging may be used to rule out other causes, but the code is assigned based on clinical presentation and history.
Treatment Options
Treatment typically involves discontinuing the stimulant, providing supportive care, and managing psychotic symptoms with antipsychotic medications. Psychotherapy or counseling may address underlying substance use. Inpatient care may be necessary for severe cases or when safety is a concern.
Prognosis and Follow-Up
Prognosis depends on the duration and severity of use, as well as response to treatment. Delusions may resolve with abstinence, but some individuals may experience persistent symptoms. Regular follow-up is important to monitor for relapse, manage co-occurring conditions, and adjust treatment as needed.
Complications
Potential complications include persistent psychosis, substance dependence, cardiovascular issues (e.g., hypertension), or social/occupational impairment. Delusions may lead to dangerous behaviors if not addressed.
Lifestyle & Prevention
Avoiding stimulant use (recreational or non-prescribed) and managing stress can reduce risk. For those with a history of substance use, seeking support or therapy may help prevent recurrence. Prescribed stimulants should be used only as directed.
When to Seek Professional Help
Seek help if psychotic symptoms (e.g., delusions, hallucinations) or stimulant use become unmanageable, or if there is risk of harm to self or others. Early intervention improves outcomes.
Tips for Medical Coders
This code is specific to stimulant-induced psychotic disorder with delusions and requires clear documentation of both the stimulant use and the presence of delusions. Ensure the clinical record supports the diagnosis without specifying dependence or abuse patterns. The code is not applicable if delusions are absent or if the psychotic disorder is due to another cause.